ProteinWWC1: A Promising Cancer Research Area (G23286)

Target Name: WWC1

NCBI ID: G23286

WWC1

ProteinWWC1: A Promising Cancer Research Area

World Wide Cancer Research Fund (WWCRF) is a non-profit organization that aims to accelerate the fight against cancer by supporting and funding cancer research projects around the world. One of the organization's most promising research areas is the proteinWWC1, which has the potential to be a drug target or biomarker for various types of cancer.

The proteinWWC1 is a protein that is expressed in various tissues and cells throughout the body, including the brain, gastrointestinal tract, and skin. It is made up of four subunits, which are involved in various cellular processes such as cell signaling, cell adhesion, and tissue repair.

One of the most promising aspects of proteinWWC1 is its potential as a drug target. Cancer cells are known to have aberrant signaling pathways that allow them to evade the normal cellular signaling processes that keep them in check. Many cancer treatments work by targeting these signaling pathways and disrupting the ability of cancer cells to communicate with each other and with the surrounding tissue.

ProteinWWC1 is thought to be a good candidate for cancer treatment because it is involved in several signaling pathways that are often disrupted in cancer. For example, the protein is involved in the TGF-β pathway, which is a well-established cancer-promoting pathway that is involved in cell proliferation, migration, and invasion.

In addition to its potential as a drug target, proteinWWC1 also has the potential as a biomarker for cancer. This is because the protein is expressed in many different types of cancer, and its levels can be used as a marker for the disease. This is an important development in the field of cancer research, as it allows researchers to track the progress of the disease and the effectiveness of different treatments.

Another promising aspect of proteinWWC1 is its expression in the brain. The brain is a sensitive organ and is often the first place in the body where cancer spreads. Therefore, studying the expression of proteinWWC1 in the brain is of particular interest.

Research has shown that the expression of proteinWWC1 is increased in the brain in response to various types of cancer, including neurobladder cancer, ovarian cancer, and melanoma. This suggests that the protein may be a useful biomarker for tracking the presence of cancer in the brain.

In addition to its potential as a drug target and biomarker, proteinWWC1 is also of interest as a potential therapeutic target for cancer. Many cancer treatments are designed to disrupt the signaling pathways of cancer cells, and proteinWWC1 is thought to be a good candidate for disruption because of its involvement in these pathways.

In conclusion, proteinWWC1 is a promising protein that has the potential to be a drug target or biomarker for various types of cancer. Its involvement in several signaling pathways, including the TGF-β pathway, makes it a promising target for cancer treatment. Its expression in the brain also makes it a potential therapeutic target for cancer. Further research is needed to fully understand the potential of proteinWWC1 as a drug and biomarker for cancer.

Protein Name: WW And C2 Domain Containing 1

Functions: Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with NF2 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. Acts as a transcriptional coactivator of ESR1 which plays an essential role in DYNLL1-mediated ESR1 transactivation. Regulates collagen-stimulated activation of the ERK/MAPK cascade. Modulates directional migration of podocytes. Acts as a substrate for PRKCZ. Plays a role in cognition and memory performance

The "WWC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WWC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets